BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Pioneer a gold standard for CGT commercialization. Co-create a
  commercial toolkit that enables suitable\, scalable and sustainable grow
 th.\n\nWith over 20 CGTs projected to be approved by 2025\, it's clear th
 at the sky is the limit for precision medicine. But despite this unpreced
 ented growth\, unstable infrastructure\, lack of standardization and nove
 l scientific nuance means there is still no industry blueprint for succes
 sful commercialization.&nbsp\;\n\nTo realize this potential\, precision m
 edicine trailblazers must share lessons of launch success and overcome pa
 in points to allow pharma to reinforce frameworks across manufacturing\, 
 market access and reimbursement and build infallible launch strategies ac
 ross the board. Commercialization networks must go even further\, transfo
 rming our healthcare system to guarantee scalable and sustainable growth.
  &nbsp\;&nbsp\;\n\nDon't get left behind. Join us at Reuters Events: Cell
  and Gene Therapy USA Virtual\, September 20-21\, where 1500+ CGT leaders
  will pioneer a new gold standard for commercialization\, readying the wo
 rld for CGT as a frontline treatment.\n\nURLs:Booking:&nbsp\;https://go.e
 vvnt.com/1155794-2?pid=185Brochure:&nbsp\;https://go.evvnt.com/1155794-3?
 pid=185\n\nVenue details:&nbsp\;Virtual Event\, United States\n
DTEND:20220921T170000
DTSTAMP:20260512T232256Z
DTSTART:20220920T090000
LOCATION:Virtual Event\, \,
SEQUENCE:0
SUMMARY:Pioneer a gold standard for CGT commercialization. Co-create a com
 mercial toolkit that enables suitable\, scalable and sustainable growth.\
 nWith ove...
UID:efc559ea-20db-4be0-a960-bf95dca1f50a
END:VEVENT
END:VCALENDAR